Philips Healthcare is using this week's American College of Cardiology (ACC) meeting to showcase several new cardiac imaging products and technologies.
In ultrasound, Philips is introducing the X8-2t Live 3D transesophageal echocardiography (TEE) transducer, enabling increased resolution and tissue filling in 3D TEE scans, with a new acoustic design that features higher frequencies and bandwidth. The improvement enables clinicians to confidently diagnose surgical pathology in real-time, Philips said.
The company's HeartModel AI anatomical intelligence ultrasound (AIUS) application provides advanced automated quantification, 3D views, enhanced reproducibility, and time-savings for echocardiography quantification tasks. Results of a multicenter study showing the robustness of this application were recently published in the European Heart Journal, Philips said.
Philips IntelliSpace Cardiovascular offers access to advanced cardiovascular informatics applications to combine multimodality images and clinical tools in a single workspace for integrated clinical decision support. The product integrates with IntelliSpace Portal advanced visualization, IntelliSpace ECG data management, and Xper information management cath lab workflow, the company said.
Finally, the company is highlighting its recently launched Azurion image-guided therapy platform designed for a wide range of interventional procedures.
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&fit=crop&h=100&q=70&w=100)
![Representative example of a 16-year-old male patient with underlying X-linked adrenoleukodystrophy. (A, B) Paired anteroposterior (AP) chest radiograph and dual-energy x-ray absorptiometry (DXA) report shows lumbar spine (L1 through L4) areal bone mineral density (BMD). The DXA report was reformatted for anonymization and improved readability. The patient had low BMD (Z score ≤ −2.0). (C) Model (chest radiography [CXR]–BMD) output shows the predicted raw BMD and Z score in comparison with the DXA reference standard, together with interpretability analyses using Shapley additive explanations (SHAP) and gradient-weighted class activation maps. The patient was classified as having low BMD, consistent with the reference standard. AM = age-matched, DEXA = dual-energy x-ray absorptiometry, RM2 = room 2, SNUH = Seoul National University Hospital, YA = young adult.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/ai-children-bone-density.0snnf2EJjr.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
